Connexion
S'inscrire
Réinitialiser le mot de passe
Publier & Distribuer
Solutions d'édition
Solutions de distribution
Thèmes
Architecture et design
Arts
Business et économie
Chimie
Chimie industrielle
Droit
Géosciences
Histoire
Informatique
Ingénierie
Intérêt général
Linguistique et sémiotique
Littérature
Mathématiques
Musique
Médecine
Pharmacie
Philosophie
Physique
Sciences bibliothécaires et de l'information, études du livre
Sciences des matériaux
Sciences du vivant
Sciences sociales
Sport et loisirs
Théologie et religion
Études classiques et du Proche-Orient ancient
Études culturelles
Études juives
Publications
Journaux
Livres
Comptes-rendus
Éditeurs
Blog
Contact
Chercher
EUR
USD
GBP
Français
English
Deutsch
Polski
Español
Français
Italiano
Panier
Home
Journaux
Experimental and Applied Biomedical Research (EABR)
Édition 20 (2019): Edition 2 (June 2019)
Accès libre
Atherogenic Impact of Homocysteine: Can
HMG-CoA
Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?
Tamara Nikolic
Tamara Nikolic
,
Ivan Srejovic
Ivan Srejovic
,
Isidora Stojic
Isidora Stojic
,
Jovana Jeremic
Jovana Jeremic
,
Marko Folic
Marko Folic
,
Stevan Matic
Stevan Matic
,
Milena Rakocevic
Milena Rakocevic
,
Snezana Jancic
Snezana Jancic
,
Biljana Jakovljevic
Biljana Jakovljevic
,
Radmila Obrenovic
Radmila Obrenovic
,
Dusan Djuric
Dusan Djuric
et
Vladimir Zivkovic
Vladimir Zivkovic
| 30 juil. 2019
Experimental and Applied Biomedical Research (EABR)
Édition 20 (2019): Edition 2 (June 2019)
À propos de cet article
Article précédent
Article suivant
Résumé
Références
Auteurs
Articles dans cette édition
Aperçu
PDF
Citez
Partagez
Publié en ligne:
30 juil. 2019
Pages:
37 - 46
Reçu:
17 oct. 2017
Accepté:
23 oct. 2017
DOI:
https://doi.org/10.1515/sjecr-2017-0055
Mots clés
atherogenic index
,
hyperhomocysteinaemia
,
liver
,
HMG-CoA reductase inhibitors
© 2019 Tamara Nikolic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Tamara Nikolic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Ivan Srejovic
Department of Physiology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Isidora Stojic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Jovana Jeremic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Marko Folic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Stevan Matic
Department of Pathology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Milena Rakocevic
Department of Pathology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Snezana Jancic
Department of Pathology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Biljana Jakovljevic
Medical College of Applied Sciences
Belgrade, Serbia
Radmila Obrenovic
Institute for Medical Biochemistry Clinical Centre of Serbia
Belgrade, Serbia
Dusan Djuric
Faculty of Medicine, Institute of Medical Physiology “Richard Burian” University of Belgrade
Belgrade, Serbia
Vladimir Zivkovic
Department of Physiology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia